Fundraising Fox

CoreMap

Burlington, US · Founded 2016 · Delaware corporation · 1 known investors

coremapmedical.com ↗

CoreMap develops medical technology that lets physicians visualize atrial fibrillation (AF), an irregular heart arrhythmia, to inform better treatment options for patients. It targets cardiac electrophysiology and diagnostics.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

PS
Peter SpectorCo-Founder, Inventor, Chief Scientific Officer & Chairman of the Board of Clinical and Scientific Advisors
SO
Sarah O KalilPresident Secretary CEO
SK
Sarah KalilCo-Founder, President & CEO
AR
Adam RothsteinDirector
AK
Allen KamerDirector

Investors · 1

Dudley FundBurlington

Reported raises · per SEC filings

Form D private placements
▶$35.5MraisedJun 2026 · 73 investors · Other Technology
Rule 506(b)
CoreMap Raises $37M in Series C Fundingfinsmes.com · Aug 2026Medtronic invests in CoreMap’s oversubscribed $37m Series C roundsiliconrepublic.com · Jul 2026
Officers, directors & promoters on the filing
  • Sarah KalilExecutive Officer, Director
  • Gowri RamanDirector
  • Allen KamerDirector
  • Adam RothsteinDirector
Offering amount
$45M
Amount sold
$35.5M
Minimum investment
$25K
Sales commissions
$500K
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.8MraisedJul 2025 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Allen KamerDirector
  • Peter SpectorExecutive Officer, Director
  • Adam RothsteinDirector
  • Sarah O KalilExecutive Officer, Director
Offering amount
$30M
Amount sold
$6.8M
Minimum investment
$1K
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23.2MraisedFeb 2022 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Allen KamerDirector
  • Sarah KalilExecutive Officer, Director
  • Peter SpectorDirector
  • Adam RothsteinDirector
Offering amount
$28M
Amount sold
$23.2M
First sale
Jan 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.9MraisedSep 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • RONNY GINORDirector
  • ALLEN KAMERDirector
  • SARAH KALILExecutive Officer, Director
  • PETER SPECTORDirector
Offering amount
$8.9M
Amount sold
$8.9M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMay 2019 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sarah KalilExecutive Officer, Director
  • Peter S SpectorDirector
  • William GruberDirector
Offering amount
$750K
Amount sold
$500K
Minimum investment
$25K
Proceeds to insiders
$125K
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedSep 2017 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter SpectorExecutive Officer, Director
  • Sarah KalilExecutive Officer
Offering amount
$500K
Amount sold
$300K
Minimum investment
$50K
Proceeds to insiders
$100K
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news